NCT00159107

Integrative Therapy in Alcoholism

Acamprosate and Integrative Behavior Therapy in the Outpatient Treatment of Alcohol Dependents

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 371 (actual)
• Sponsor: Heinrich-Heine University, Duesseldorf · Academic / Other
• Sex: All
• Age: 25 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The main aim of this project consists in the investigation of the interaction of behavior therapy and Acamprosate in the outpatient treatment of alcoholic patients in a randomized, prospective and (regarding study medication Acamprosate vs. Placebo) double blind design. A total of 371 patients has been randomly assigned immediately after detoxification to one of three different outpatient treat-ment conditions.

Detailed description

The objective of this multi-center study is to optimize the long-term treatment of patients with alcohol dependence. This investigation should contribute to the issue of effective relapse prevention. Each treatment condition is lasting 6 months: a) Behavior Group Therapy + Acamprosate, b) Behavior Group Therapy + Placebo and c) support and counseling + Acamprosate. Follow-up examinations carried out 3 and 6 months after the end of treatment.

Conditions

• Alcoholism

Interventions

Type	Name	Description
DRUG	Acamprosate	Acamprosate
BEHAVIORAL	Integrative behavior therapy	Integrative behavior therapy
DRUG	Placebo	Placebo

Timeline

• Start date: 2003-05-01
• Completion: 2006-12-01
• First posted: 2005-09-12
• Last updated: 2008-01-30

Locations

1 site across 1 country: Germany